About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT06499272

Quality-of-Life-and-Cognitive-Oriented Rehabilitation Through the NeuronUP in Alzheimer's Disease

Introduction: New technologies are a support in the rehabilitation of users. The therapeutic approach to cognitive rehabilitation encompasses a variety of techniques, among which traditional occupatio...

Lead sponsor: Universidad Rey Juan Carlos•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Universidad Rey Juan Carlos

Age

65 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adult men or women, aged 65 years or olde.
•Not present severe cognitive impairment, measured through the Mini Cognitive Examination test (MEC\>22 points).
•To reside permanently in the Nursing Home.
•Attend Occupational Therapy sessions regularly.
•Have adequate manual dexterity to be able to use a Tablet.
•Agree to participate voluntarily in the study.

Exclusion Criteria

•Having severe cognitive impairment, as measured by the Mini Cognitive Examination (MEC\<22 points).
•Having comorbid diagnoses such as stroke, brain tumours or heart disease, among others.
•Not attending Occupational Therapy sessions regularly.
•Poor adherence to the treatments offered at the centre.
•Not agreeing to participate voluntarily in the study.

Related studies

RECRUITINGPhase 3

Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease

NCT07571161 · Alzheimer Disease

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

RECRUITINGPhase 2

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

NCT06847321 · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis

Functional Vision and Quality of Life in a Modern Society - With Emphasis on Myopia and Cerebral Visual Impairment Among Youth

NCT07653074 · Myopia, Quality of Life

RECRUITINGPhase 3

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

NCT06937229 · Alzheimer Disease, Agitation

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 12, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment35

Start dateDec 2023

Last updatedJul 12, 2024

Condition

Alzheimer Disease Occupational Therapy Quality of Life Cognitive Impairment Older People

Locations shown

Physiocare Madrid Clinic

Madrid

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 12, 2024Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions